PRINTO (the Paediatric Rheumatology International Trials Organisation)
1 other identifier
observational
N/A
1 country
1
Brief Summary
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 22, 2006
CompletedFirst Posted
Study publicly available on registry
December 25, 2006
CompletedDecember 25, 2006
December 1, 2006
December 22, 2006
December 23, 2006
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Any child with JIA who has gone into remission using methotrexate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rheumatology ICH
London, WC1N 1EH, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucy Wedderburn, Dr
Institute Of Child Health and Great Ormond Street Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 22, 2006
First Posted
December 25, 2006
Study Completion
December 1, 2006
Last Updated
December 25, 2006
Record last verified: 2006-12